Dexcom Inc

Carnegie Investment Counsel DXCM

Report date

9/30/2025

Quarter

2025 Q3

Filed

10/16/2025

Shares

3,430

Value ($000)

231

Weight

0.0%

2020 Q2 - 2025 Q3 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	10/16/2025	231	0.0%	3,430	9/30/2025
2025 Q2	7/31/2025	308	0.0%	3,530	6/30/2025
2025 Q1	5/6/2025	218	0.0%	3,530	3/31/2025
2024 Q4	1/15/2025	275	0.0%	3,530	12/31/2024
2024 Q3	10/10/2024	213	0.0%	3,180	9/30/2024
2024 Q2	7/22/2024	595	0.0%	5,248	6/30/2024
2024 Q1	5/6/2024	742	0.0%	5,348	3/31/2024
2023 Q4	1/30/2024	671	0.0%	5,410	12/31/2023
2023 Q3	10/11/2023	505	0.0%	5,409	9/30/2023
2023 Q2	8/4/2023	687	0.0%	5,349	6/30/2023
2023 Q1	4/20/2023	617	0.0%	5,315	3/31/2023
2022 Q4	1/24/2023	602	0.0%	5,317	12/31/2022
2022 Q3	10/14/2022	428	0.0%	5,312	9/30/2022
2022 Q2	8/2/2022	396	0.0%	5,312	6/30/2022
2022 Q1	4/11/2022	626	0.0%	1,223	3/31/2022
2021 Q4	1/21/2022	704	0.0%	1,312	12/31/2021
2021 Q3	10/8/2021	640	0.0%	1,170	9/30/2021
2021 Q2	7/16/2021	398	0.0%	933	6/30/2021
2021 Q1	4/12/2021	335	0.0%	933	3/31/2021
2020 Q4	2/8/2021	332	0.0%	898	12/31/2020
2020 Q3	10/13/2020	391	0.0%	948	9/30/2020
2020 Q2	7/9/2020	247	0.0%	610	6/30/2020